Project Details
Description
CD4 REDIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY FOR CD4 POSITIVE T CELL NEOPLASMS
| Status | Finished |
|---|---|
| Effective start/end date | 09/20/20 → 11/8/21 |
Funding
- US Food and Drug Administration: $260,033.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.